Clinical Trial Update: Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy findings for Glyco pMDI in COPD across Phase 1 and Phase 2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Glyco pMDI

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1, Phase 2 | Status: COMPLETED